EMPACOZA TRIO10&5&1000MG30TAB

Empacoza Trio is a triple-combination oral antidiabetic medication used for the management of type 2 diabetes mellitus. It combines Empagliflozin, Linagliptin, and Metformin to provide comprehensive glycemic control. Empagliflozin works by increasing glucose excretion in the urine, Linagliptin enhances insulin secretion and reduces glucose production, and Metformin improves insulin sensitivity and decreases hepatic glucose output. This combination is intended for adult patients who require multiple agents to achieve their target blood sugar levels alongside diet and exercise.